SA finalising R25m investment to boost pan-African vaccine manufacturing capabilities

  • 📰 TheCitizen_News
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 75%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

The SA Medical Research Council and the department of science and innovation have provided R10 million funding for the first South African Covid-19 vaccine trial.

South Africa is in the process of finalising a R25 million investment to boost pan-African Covid-19 vaccine manufacturing capabilities.

“We are currently in the process of finalising a R25 million investment to boost pan-African vaccine manufacturing capabilities through the African Renaissance Fund.” “As the international community, we have been unanimous that services, supplies, products and technologies for prevention, treatment and care of COVID-19 must be available to all. No country must be left behind.”

“One looks for instance at the advances in ventilator development and production in developing countries.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 6. in İD

Indonesia Berita Terbaru, Indonesia Berita utama